Rolf Kiessling is a professor of Experimental Oncology at Karolinska Institutet since 1995 and has a part-time position as Chief Physician at Radiumhemmet, Karolinska hospital. R.K. has published more than 200 publications in peer review journals and has broad scientific expertise in the field of experimental and clinical immunology. Among his earliest achievements, he discovered and named the NK- cell during the mid 70s, a discovery for which he was awarded ”Anders Jahres medicinska pris for yngre forskare” 1985 and ”Erik Fehrnströms pris” 1989. A more recent research focus of his group has been the area of immune therapy of cancer where his group is carrying out investigator initiated clinical trials on cancer patients and also performing basic research in pre-clinical animal models.
Scientific Advisory Board
Immunicum’s Scientific Advisory Board represents a group of individuals with a broad competence and extensive experience from the Life Science industry.
Member of the SAB
M.D., Ph.D. Professor of Experimental Oncology, Karolinska Institutet
Member of the SAB
M.D., Ph.D. Professor of Experimental Oncology
Roger Henriksson is professor of experimental oncology and Chief Physician, Medical Oncology and Radiotherapy since 1994. He has also served as Senior Medical Director (advisor) at Astra Zeneca, globally, part time since 2000. Roger Henriksson has published more than 270 publications in peer reviewed journals regarding all phases of drug development. Current scientific positions include Head/Deputy Head of the Dept of Radiation Sciences, Chairman of the National (Nordic 2001) Group for Treatment of cns Tumours, Member of the Scientific Advisory Board for the Swedish Cancer Society, Board Member of the National Group for Treatment of Lung cancer.